TY - JOUR
T1 - Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson’s disease over seven years in a cohort
T2 - a comparative analysis
AU - Hanff, Anne Marie
AU - Krüger, Rejko
AU - Acharya, Geeta
AU - Aguayo, Gloria
AU - Alexandre, Myriam
AU - Ammerlaan, Wim
AU - Batutu, Roxane
AU - Beaumont, Katy
AU - Béchet, Sibylle
AU - Berchem, Guy
AU - Boussaad, Ibrahim
AU - Contesotto, Gessica
AU - de Bremaeker, Nancy
AU - Ferrari, Angelo
AU - Fritz, Joëlle
AU - Gamio, Carlos
AU - Gantenbein, Manon
AU - georges, Laura
AU - Giraitis, Marijus
AU - Graas, Jérôme
AU - Henry, Estelle
AU - Henry, Margaux
AU - Hundt, Alexander
AU - Jónsdóttir, Sonja
AU - Klucken, Jochen
AU - Kofanova, Olga
AU - Lambert, Pauline
AU - Landoulsi, Zied
AU - Lopes, Ana Festas
AU - Lorentz, Victoria
AU - Marques, Tainá M.
AU - Marques, Guilherme
AU - Mcintyre, Deborah
AU - Mediouni, Chouaib
AU - Mendibide, Alexia
AU - Menster, Myriam
AU - Mittelbronn, Michel
AU - Mtimet, Saïda
AU - Munsch, Maeva
AU - Nehrbass, Ulf
AU - Nickels, Sarah
AU - Noor, Fozia
AU - Pauly, Claire
AU - Pauly, Laure
AU - Pavelka, Lukas
AU - Perquin, Magali
AU - Pexaras, Achilleas
AU - Rauschenberger, Armin
AU - Remark, Lucie
AU - Richard, Ilsé
AU - Roland, Olivia
AU - Sapienza, Stefano
AU - Sharify, Amir
AU - Sokolowska, Kate
AU - Theresine, Maud
AU - Thien, Hermann
AU - Trouet, Johanna
AU - Vaillant, Michel
AU - Vega, Carlos
AU - Zelimkhanov, Gelani
AU - on behalf of NCER-PD
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8/24
Y1 - 2024/8/24
N2 - Introduction: While there is an interest in defining longitudinal change in people with chronic illness like Parkinson’s disease (PD), statistical analysis of longitudinal data is not straightforward for clinical researchers. Here, we aim to demonstrate how the choice of statistical method may influence research outcomes, (e.g., progression in apathy), specifically the size of longitudinal effect estimates, in a cohort. Methods: In this retrospective longitudinal analysis of 802 people with typical Parkinson’s disease in the Luxembourg Parkinson's study, we compared the mean apathy scores at visit 1 and visit 8 by means of the paired two-sided t-test. Additionally, we analysed the relationship between the visit numbers and the apathy score using linear regression and longitudinal two-level mixed effects models. Results: Mixed effects models were the only method able to detect progression of apathy over time. While the effects estimated for the group comparison and the linear regression were smaller with high p-values (+ 1.016/ 7 years, p = 0.107, -0.056/ 7 years, p = 0.897, respectively), effect estimates for the mixed effects models were positive with a very small p-value, indicating a significant increase in apathy symptoms by + 2.345/ 7 years (p < 0.001). Conclusion: The inappropriate use of paired t-tests and linear regression to analyse longitudinal data can lead to underpowered analyses and an underestimation of longitudinal change. While mixed effects models are not without limitations and need to be altered to model the time sequence between the exposure and the outcome, they are worth considering for longitudinal data analyses. In case this is not possible, limitations of the analytical approach need to be discussed and taken into account in the interpretation.
AB - Introduction: While there is an interest in defining longitudinal change in people with chronic illness like Parkinson’s disease (PD), statistical analysis of longitudinal data is not straightforward for clinical researchers. Here, we aim to demonstrate how the choice of statistical method may influence research outcomes, (e.g., progression in apathy), specifically the size of longitudinal effect estimates, in a cohort. Methods: In this retrospective longitudinal analysis of 802 people with typical Parkinson’s disease in the Luxembourg Parkinson's study, we compared the mean apathy scores at visit 1 and visit 8 by means of the paired two-sided t-test. Additionally, we analysed the relationship between the visit numbers and the apathy score using linear regression and longitudinal two-level mixed effects models. Results: Mixed effects models were the only method able to detect progression of apathy over time. While the effects estimated for the group comparison and the linear regression were smaller with high p-values (+ 1.016/ 7 years, p = 0.107, -0.056/ 7 years, p = 0.897, respectively), effect estimates for the mixed effects models were positive with a very small p-value, indicating a significant increase in apathy symptoms by + 2.345/ 7 years (p < 0.001). Conclusion: The inappropriate use of paired t-tests and linear regression to analyse longitudinal data can lead to underpowered analyses and an underestimation of longitudinal change. While mixed effects models are not without limitations and need to be altered to model the time sequence between the exposure and the outcome, they are worth considering for longitudinal data analyses. In case this is not possible, limitations of the analytical approach need to be discussed and taken into account in the interpretation.
KW - Cohort studies
KW - Disease progression
KW - Epidemiology
KW - Lost to follow-up
KW - Parkinson
KW - Statistical model
UR - http://www.scopus.com/inward/record.url?scp=85202267202&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/39182059/
U2 - 10.1186/s12874-024-02301-7
DO - 10.1186/s12874-024-02301-7
M3 - Article
C2 - 39182059
AN - SCOPUS:85202267202
SN - 1471-2288
VL - 24
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
IS - 1
M1 - 183
ER -